What You Should Know:
- Salt AI, a company founded by the high-performance computing (HPC) team behind MySpace, is making significant strides in AI-driven drug discovery through its research partnership with the Ellison Medical Institute, led by cancer researcher Dr. David Agus.
- The partnership signifies Salt AI's formal entry into the life sciences sector and has already yielded notable advancements. Key among these is the ability to run AlphaFold2, a foundation model
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Reduce Clinical Trial Burden with Flatiron Clinical Pipe™: EHR-to-EDC Integration
What You Should Know:
- Flatiron Health, a healthcare technology company, today announced a collaboration with the University of Colorado Comprehensive Cancer Center (CU Cancer Center) and UCHealth to implement Flatiron Clinical Pipe™, an innovative solution that streamlines data capture for clinical trials.
- The partnership aims to accelerate cancer research and improve patient care by reducing administrative burden and enhancing the efficiency of clinical
Read More
Medisafe and EMD Serono Partner to Launch Global HIV Resource Center
What You Should Know:
- Medisafe, a global digital health platform for medication management announced a strategic collaboration with EMD Serono to launch the HIV Resource Center by Medisafe.
- The HIV Resource Center by Medisafe puts patients at the center of their care by providing personalized support, education, and proactive health monitoring.
Addressing the Challenges of HIV Management
Living with HIV can present various challenges, including managing complex
Read More
The Role of Biomechanics in Designing High-Performance Spinal Implants
Spinal implants treat conditions that affect the spine, such as deformities, trauma, and degenerative diseases. The success of these implants depends on their design, which must align with the biomechanics of the human body. Innovasis, a leader in spinal implant technology, emphasizes biomechanics to develop implants that enhance patient outcomes. By understanding how mechanical forces interact with the spine, Innovasis ensures that its implants provide optimal support, promote healing, and
Read More
The Future of Advanced Therapeutics: Opportunities and Challenges
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.
mRNA Vaccines: Revolutionizing Disease Prevention
Messenger RNA (mRNA) vaccines have gained prominence,
Read More
Validose Raises $2M to Combat Clinical Trial Non-Adherence with AI-Powered Medication Delivery
What You Should Know:
- Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced today the successful close of a $2 million pre-seed funding round.
- The round was led by Peter Bauer’s Family Office as part of its Technology for Humanity strategy, 10XBeta, and Interstate Fusion Ventures; several angel investors participated.
Validose Revolutionizes Medication Adherence and Precision Dosing
Validose, a healthcare technology company and
Read More
Advancing Drug Development and Regulatory Compliance with AI-Enhanced Real-World Evidence
In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical research and regulatory decisions, recognizing its potential to enhance drug development and improve patient outcomes. This shift includes a focus on sourcing RWD that adheres to strict regulatory standards for effective use in drug approvals and postmarket surveillance.
Unlike traditional
Read More
Medidata Integrates UK Costing Data into Grants Manager, Streamlining Clinical Trial Budgeting
What You Should Know:
- Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions, today announced the integration of data from the UK interactive Costing Tool (iCT) into its Grants Manager platform.
- The collaboration with the National Institute for Health and Care Research (NIHR) provides life sciences organizations with a streamlined and standardized approach to clinical trial budgeting, enhancing efficiency and transparency in research
Read More
Flatiron Health and Exact Sciences Partner to Accelerate Clinical Evidence Generation for MRD Testing in Oncology
What You Should Know:
- Flatiron Health, a leading technology company focused on improving cancer care announced a strategic partnership with Exact Sciences, a pioneer in cancer screening and diagnostics to accelerate clinical evidence generation for Exact Sciences' molecular residual disease (MRD) test, Oncodetect™.
- The collaboration will leverage Flatiron's innovative clinical research platform and extensive network of community oncology practices to study the test's performance
Read More
Helix Launches Largest Clinico-Genomic Data Cohort to Optimize GLP-1’s
What You Should Know:
- Helix, a leader in population genomics and precision health, today announced the launch of a new clinico-genomic dataset comprising over 15,000 patients treated with glucagon-like peptide-1 (GLP-1) agonists.
- These medications, which include semaglutide, tirzepatide, and liraglutide, are increasingly used to treat type 2 diabetes, obesity, and other metabolic conditions.
GLP-1 Agonist Virtual Registry
This research-ready dataset, known as a
Read More
